Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

被引：0
|
作者：
Iacopetta, B.
Watanabe, T.
机构：
[1] Univ Western Australia, Sch Surg & Pathol M507, Nedlands, WA 6009, Australia
[2] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan
来源：
GUT | 2006年 / 55卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1671 / 1672
页数：3
相关论文
共 50 条
  • [1] Microsatellite instability in colorectal cancer. Prognostic significance and role in the prediction of benefit from adjuvant chemotherapy
    Jover, R
    GASTROENTEROLOGY, 2004, 126 (04) : A390 - A390
  • [2] Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability
    Watanabe, T
    Kanazawa, T
    Kazama, Y
    Tanaka, J
    Tanaka, T
    Ishihara, S
    Nagawa, H
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3866 - 3867
  • [3] Microsatellite Instability and Adjuvant Fluorouracil Chemotherapy: A Mismatch?
    Ng, Kimmie
    Schrag, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3207 - 3210
  • [4] Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
    Ribic, CM
    Sargent, DJ
    Moore, MJ
    Thibodeau, SN
    French, AJ
    Goldberg, RM
    Hamilton, SR
    Laurent-Puig, P
    Gryfe, R
    Shepherd, LE
    Tu, D
    Redston, M
    Gallinger, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03): : 247 - 257
  • [5] Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability -: Response
    Benatti, P
    de Leon, MP
    Gafà, R
    Lanza, G
    Barana, D
    Oliani, C
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3867 - 3867
  • [6] Prognostic value of microsatellite instability in adjuvant treatment of colorectal cancer
    Potapov, Oleksii A.
    Glagolieva, Anastasia Y.
    Makhmudov, Dmytro E.
    Komorowski, Andrzej L.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 540 - 546
  • [7] Thymidylate synthase expression in colorectal cancer:: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy
    Edler, D
    Glimelius, B
    Hallström, M
    Jakobsen, A
    Johnston, PG
    Magnusson, I
    Ragnhammar, P
    Blomgren, H
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1721 - 1728
  • [8] Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer
    Jover, R.
    Zapater, P.
    Castells, A.
    Llor, X.
    Andreu, M.
    Cubiella, J.
    Pinol, V.
    Xicola, R. M.
    Bujanda, L.
    Rene, J. M.
    Clofent, J.
    Bessa, X.
    D Morillas, J.
    Nicolas-Perez, D.
    Paya, A.
    Alenda, C.
    GUT, 2006, 55 (06) : 848 - 855
  • [9] Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer''
    Mondaca, Sebastian
    Yoon, Sam S.
    Strong, Vivian E.
    Ku, Geoffrey Y.
    Ilson, David H.
    Greally, Megan
    Janjigian, Yelena Y.
    ANNALS OF SURGERY, 2019, 270 (02) : E39 - E40
  • [10] Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit
    Thomas, Michelle L.
    Hewett, Peter J.
    Ruszkiewicz, Andrew R.
    Moore, James W. E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (04) : 343 - 351
12345